Gastroenterology

Study reveals the trajectory of phages in the infant gut ecosystem

The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.

The role of gut microbiota and mycobiota in pre-eclampsia

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

IBS DAYS 2024 in Bologna with experts from all over the world 

Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.

How gut bacteria can help relieve constipation

A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.

In Crohn’s disease model, a fiber-free diet inhibits colitis by regulating gut bacteria

The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.

Gut fungi may be linked to inflammation in severe COVID

The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.

Unraveling disease-specific patterns: loss of microbial cross-feeding in the human gut

Focusing on restoring microbial cross-feeding interactions emerges as a promising mechanism-informed strategy to reconstruct a healthy gut ecosystem.

Immune responses to gut microbes may indicate who benefits from diabetes therapy

The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top